146 related articles for article (PubMed ID: 31152486)
1. Inhibition of the mTOR pathway: A new mechanism of β cell toxicity induced by tacrolimus.
Rodriguez-Rodriguez AE; Donate-Correa J; Rovira J; Cuesto G; Luis-Ravelo D; Fernandes MX; Acevedo-Arozena A; Diekmann F; Acebes A; Torres A; Porrini E
Am J Transplant; 2019 Dec; 19(12):3240-3249. PubMed ID: 31152486
[TBL] [Abstract][Full Text] [Related]
2. Deciphering Tacrolimus-Induced Toxicity in Pancreatic β Cells.
Triñanes J; Rodriguez-Rodriguez AE; Brito-Casillas Y; Wagner A; De Vries APJ; Cuesto G; Acebes A; Salido E; Torres A; Porrini E
Am J Transplant; 2017 Nov; 17(11):2829-2840. PubMed ID: 28432716
[TBL] [Abstract][Full Text] [Related]
3. The higher diabetogenic risk of tacrolimus depends on pre-existing insulin resistance. A study in obese and lean Zucker rats.
Rodriguez-Rodriguez AE; Triñanes J; Velazquez-Garcia S; Porrini E; Vega Prieto MJ; Diez Fuentes ML; Arevalo M; Salido Ruiz E; Torres A
Am J Transplant; 2013 Jul; 13(7):1665-75. PubMed ID: 23651473
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus inhibits insulin release and promotes apoptosis of Min6 cells through the inhibition of the PI3K/Akt/mTOR pathway.
Tong L; Li W; Zhang Y; Zhou F; Zhao Y; Zhao L; Liu J; Song Z; Yu M; Zhou C; Yu A
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278483
[TBL] [Abstract][Full Text] [Related]
5. Glucose homeostasis changes and pancreatic β-cell proliferation after switching to cyclosporin in tacrolimus-induced diabetes mellitus.
Rodríguez-Rodríguez AE; Triñanes J; Porrini E; Velázquez-García S; Fumero C; Vega-Prieto MJ; Díez-Fuentes ML; Luis Lima S; Salido E; Torres A
Nefrologia; 2015; 35(3):264-72. PubMed ID: 26299169
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus- and sirolimus-induced human β cell dysfunction is reversible and preventable.
Dai C; Walker JT; Shostak A; Padgett A; Spears E; Wisniewski S; Poffenberger G; Aramandla R; Dean ED; Prasad N; Levy SE; Greiner DL; Shultz LD; Bottino R; Powers AC
JCI Insight; 2020 Jan; 5(1):. PubMed ID: 31941840
[TBL] [Abstract][Full Text] [Related]
7. Induction of diabetes by Tacrolimus in a phenotypic model of obesity and metabolic syndrome.
Teixidó-Trujillo S; Porrini E; Menéndez-Quintanal LM; Torres-Ramírez A; Fumero C; Rodríguez-Rodríguez AE
Front Endocrinol (Lausanne); 2024; 15():1388361. PubMed ID: 38745946
[TBL] [Abstract][Full Text] [Related]
8. Effect of Empagliflozin on Tacrolimus-Induced Pancreas Islet Dysfunction and Renal Injury.
Jin J; Jin L; Luo K; Lim SW; Chung BH; Yang CW
Am J Transplant; 2017 Oct; 17(10):2601-2616. PubMed ID: 28422431
[TBL] [Abstract][Full Text] [Related]
9. Atorvastatin Targets the Islet Mevalonate Pathway to Dysregulate mTOR Signaling and Reduce β-Cell Functional Mass.
Shen L; Gu Y; Qiu Y; Cheng T; Nie A; Cui C; Fu C; Li T; Li X; Fu L; Wang Y; Ni Q; Wang Q; Wang W; Feng B
Diabetes; 2020 Jan; 69(1):48-59. PubMed ID: 31649162
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of calcineurin in the prefrontal cortex induced depressive-like behavior through mTOR signaling pathway.
Yu JJ; Zhang Y; Wang Y; Wen ZY; Liu XH; Qin J; Yang JL
Psychopharmacology (Berl); 2013 Jan; 225(2):361-72. PubMed ID: 22875481
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporin and tacrolimus impair insulin secretion and transcriptional regulation in INS-1E beta-cells.
Øzbay LA; Smidt K; Mortensen DM; Carstens J; Jørgensen KA; Rungby J
Br J Pharmacol; 2011 Jan; 162(1):136-46. PubMed ID: 20825407
[TBL] [Abstract][Full Text] [Related]
12. Hyperglycemia induced by tacrolimus and sirolimus is reversible in normal sprague-dawley rats.
Shivaswamy V; McClure M; Passer J; Frahm C; Ochsner L; Erickson J; Bennett RG; Hamel FG; Larsen JL
Endocrine; 2010 Jun; 37(3):489-96. PubMed ID: 20960173
[TBL] [Abstract][Full Text] [Related]
13. 1, 25(OH)2D3 protects β cell against high glucose-induced apoptosis through mTOR suppressing.
Yang Z; Liu F; Qu H; Wang H; Xiao X; Deng H
Mol Cell Endocrinol; 2015 Oct; 414():111-9. PubMed ID: 26213322
[TBL] [Abstract][Full Text] [Related]
14. Antiaging Glycopeptide Protects Human Islets Against Tacrolimus-Related Injury and Facilitates Engraftment in Mice.
Gala-Lopez BL; Pepper AR; Pawlick RL; O'Gorman D; Kin T; Bruni A; Abualhassan N; Bral M; Bautista A; Manning Fox JE; Young LG; MacDonald PE; Shapiro AM
Diabetes; 2016 Feb; 65(2):451-62. PubMed ID: 26581595
[TBL] [Abstract][Full Text] [Related]
15. Unique cellular and mitochondrial defects mediate FK506-induced islet β-cell dysfunction.
Rostambeigi N; Lanza IR; Dzeja PP; Deeds MC; Irving BA; Reddi HV; Madde P; Zhang S; Asmann YW; Anderson JM; Schimke JM; Nair KS; Eberhardt NL; Kudva YC
Transplantation; 2011 Mar; 91(6):615-23. PubMed ID: 21200364
[TBL] [Abstract][Full Text] [Related]
16. Calcineurin inhibitors acutely improve insulin sensitivity without affecting insulin secretion in healthy human volunteers.
Øzbay LA; Møller N; Juhl C; Bjerre M; Carstens J; Rungby J; Jørgensen KA
Br J Clin Pharmacol; 2012 Apr; 73(4):536-45. PubMed ID: 21988494
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Kinase-Dead mTOR Impairs Glucose Homeostasis by Regulating Insulin Secretion and Not β-Cell Mass.
Alejandro EU; Bozadjieva N; Blandino-Rosano M; Wasan MA; Elghazi L; Vadrevu S; Satin L; Bernal-Mizrachi E
Diabetes; 2017 Aug; 66(8):2150-2162. PubMed ID: 28546423
[TBL] [Abstract][Full Text] [Related]
18. Molecular Pathways Leading to Induction of Cell Death and Anti-Proliferative Properties by Tacrolimus and mTOR Inhibitors in Liver Cancer Cells.
Navarro-Villarán E; de la Cruz-Ojeda P; Contreras L; González R; Negrete M; Rodríguez-Hernández MA; Marín-Gómez LM; Álamo-Martínez JM; Calvo A; Gómez-Bravo MA; de la Cruz J; Padillo J; Muntané J
Cell Physiol Biochem; 2020 May; 54(3):457-473. PubMed ID: 32369692
[TBL] [Abstract][Full Text] [Related]
19. Effects of metformin on hyperglycemia in an experimental model of tacrolimus- and sirolimus-induced diabetic rats.
Jin J; Lim SW; Jin L; Yu JH; Kim HS; Chung BH; Yang CW
Korean J Intern Med; 2017 Mar; 32(2):314-322. PubMed ID: 27688296
[TBL] [Abstract][Full Text] [Related]
20. FK506-binding protein (FKBP12) regulates ryanodine receptor-evoked Ca2+ release in colonic but not aortic smooth muscle.
MacMillan D; Currie S; McCarron JG
Cell Calcium; 2008 Jun; 43(6):539-49. PubMed ID: 17950843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
